English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
iCMLf Conversations on CML and COVID-19 - Join Professor Gianantonio Rosti on July 2nd at 16.00 CET
June 2020 - Please join us for the second in our series of conversations with renowned CML experts on managing CML during this pandemic. On July 2nd Professor Gianantonio Rosti will be sharing his experience and perspectives.
Management recommendations for patients with CML during the pandemic
Professor Gianantonio Rosti, St Orsola University Hospital, Bologna (Italy)
July 2nd at 16.00 Central European time (CET)
What will be discussed during the conversation with Professor Rosti?
During the 45 min webinar we will discuss the following questions:
- Treatment recommendations for patients with CML during the pandemic
- How to begin therapy in a newly diagnosed CML patient
- Should CML treatment be adjusted, switched, or stopped pre-emptively?
- Should the monitoring schedule be adjusted?
- What should be considered for those patients in TFR, or considering TFR?
iCMLf Conversations on CML and COVID-19 - Join Professor Jorge Cortes on June 24th at 15.00 CET
June 2020 - Please join us for the first in a series of conversations with renowned CML experts on managing CML during this pandemic. On June 24th Professor Jorge Cortes will be sharing his experience and perspectives.
An overview of CML in the era of the COVID-19 pandemic
Professor Jorge Cortes, Georgia Cancer Center, Augusta (USA)
June 24th at 15.00 Central European time (CET)
What will be discussed during the conversation with Professor Cortes?
During the 45 min webinar we will discuss the following questions:
- An overview of our current knowledge
- Advice for CML patients
- Risk and prognosis for people with CML and COVID-19
- CML therapy during the pandemic
- Do TKI's have a protective effect or not?
- Does interferon have a positive effect?
Conversations on COVID-19 and CML - save the date for these iCMLf webinars
June 2020 - The International CML Foundation is holding a series of four webinars focused on the care of people with CML during the COVID-19 crisis.
Beginning in late June, for four weeks, we will be hosting conversations with renowned experts in CML, who will be sharing their experiences and perspectives, also addressing key questions around CML and COVID-19.
An important part of each conversation will be questions from the audience.
Please join us on the following webinars:
Virtual Edition of the 25th Congress of EHA: Overview of CML sessions available
June 2020 - The 25th Congress of the European Hematology Association (EHA) will be held as a virtual meeting. The 10-day program will take place from June 11-21, 2020. On-demand sessions will be accessible until October 15, 2020.
To help you plan your CML meeting schedule for the 25th EHA Congress, we have compiled a list of all CML related sessions for your convenience. This include on-demand sessions, live sessions and a list of abstracts.
Download the CML Session overview here
To register for the 25th Congress of EHA click here
An Expert Opinion: Interferon and CML during the COVID-19 Pandemic
May 2020 - During this pandemic, we continuously strive to provide you with current information about COVID-19 and CML. This also includes individual expert opinions on various topics related to COVID-19 and CML.
Today we are pleased to share with you an expert opinion on interferon and CML during the COVID-19 pandemic by Professor Jeff Lipton from the Princess Margaret Hospital in Toronto, Canada.
You will find this and other expert opinions on the iCMLf COVID-19 hub that will continously be updated with recent information on COVID-19 and CML.
Please read the full expert opinion below.
The iCMLf CURE Consortium - Concerted global effort working towards a cure for CML
April 2020 - In addition to our current, urgent commitment to support the CML community with reliable information about COVID-19 and CML during the pandemic, we also continue with our efforts working towards a cure for CML.
Thanks to the funds raised with the Climb for a cure Mount Kilimanjaro in November 2019 we can now begin projects within the iCMLf CURE CONSORTIUM. The iCMLf Genomics Alliance is investigating the role particular somatic mutations play in clinical outcomes. The new iCMLf TFR Alliance, will explore key factors responsible for both successful and unsuccessful treatment free remission attempts.
